Real-time disaster intelligence, alerts, and response tools.
Tuesday, April 21, 2026
[ad_1] Studies show promising new options to address unmet needs in sickle cell disease and immune thrombocytopenia SAN DIEGO, Dec. 7, 2024 /PRNewswire/ — Researchers report significant progress toward expanding the therapeutic options available for people […]
[ad_1] 73% of the NKTR-255 treatment group compared to 50% of the placebo group achieved a complete response at 6 months NKTR-255 enhanced CAR T-cell kinetics with improved CD8+ CAR-T area under the curve (AUC) […]
[ad_1] NEW TAIPEI CITY, Dec. 6, 2024 /PRNewswire/ — Caliway Biopharmaceuticals Co., Ltd. (TWSE-6919) is proud to announce its inclusion in the FTSE TWSE Taiwan Mid-Cap 100 Index and the FTSE TWSE Taiwan Eight Industries […]
[ad_1] SILVER SPRING, Md., Nov. 22, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA published the FDA Voices: […]
[ad_1] SHANGHAI, Nov. 21, 2024 /PRNewswire/ — 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream […]
